Truist Raises Price Target on Elevance Health to $500

Truist has raised its price target for Elevance Health, Inc. (ticker: ELV) to $500 from $475, while maintaining a Buy rating on the stock. This adjustment is part of a broader set of analyst updates reflecting revised market expectations for the health insurance provider, reported on October 22, 2026.